Effect of Adjuvant Chemotherapy on Elderly Stage II High-Risk Colorectal Cancer Patients

Abstract

Among elderly patients with stage II high-risk colorectal cancer, the AC+ group did not show better RFS or OS than the AC- group. However, selected patients with more than 2 adverse features might benefit from AC.